Display Settings:

Format

Send to:

Choose Destination

    Clin Nucl Med. 2006 Jul;31(7):376-8.

    Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation.

    Bonte FJ, Harris TS, Hynan LS, Bigio EH, White CL 3rd.

    Nuclear Medicine Center, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9061, USA. Frederick.Bonte@UTSouthwestern.edu

    PURPOSE: The purpose of this study is to determine the value of Tc-99m HMPAO SPECT in the diagnosis of the dementias, with particular reference to Alzheimer disease. MATERIALS AND METHODS: Tc-99m HMPAO was used with a 3-camera scanner to produce 5 sets of sectional images of the brain. Diagnosis was made by a physician blinded to the clinical diagnosis. Results in 49 subjects were ultimately compared with neuropathologic study of the brain at autopsy. RESULTS: Sensitivity = 86.7% (68.4-95.6%, 95% confidence interval [CI]), specificity = 89.5% (65.5-98.2% CI), positive predictive value = 92.9% (75.0-98.8% CI), negative predictive value = 81% (57.4-93.7% CI), accuracy = 87.8% (74.5-94.9% CI), likelihood ratio = 8.23% (7.09-9.57% CI). CONCLUSIONS: Comparison is made with several other SPECT and PET series with histopathologic correlation. Brain blood flow SPECT is useful in the diagnosis and differential diagnosis of the dementias.

    PMID: 16785801 [PubMed - indexed for MEDLINE]

    Supplemental Content